Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

Research To Practice | Oncology Videos · Feb 8, 2023 · 1h 3m

Featuring perspectives from Drs Michael Birrer and Kathleen Moore, including the following topics:

Gynecologic Oncology

Introduction (0:00)

Ovarian Cancer

PARP inhibitors as primary maintenance (8:11)

PARP inhibitors for recurrent and metastatic disease (19:04)

Antibody-drug conjugates: Mirvetuximab soravtansine; upifitamab rilsodotin (31:39)

Endometrial Cancer

Immunotherapy for metastatic disease (43:49)

Selinexor as maintenance therapy (51:33)

Other novel agents (56:52)

Cervical Cancer

Immunotherapy for metastatic disease and the antibody-drug conjugate tisotumab vedotin (1:01:00)

CME…